Neural/Glial Cell-Derived Nanoparticles to Restore Neural Function in Alzheimer’s Disease
Asset/Technology Type
Therapeutic/Drug Delivery Agent
Description of Invention
The invention is an engineered biomimetic nanoparticle (NP) that integrates neural or glial cell membrane proteins into lipid-based nanoparticles (a.k.a. neurosomes). The integration of these neural/glial cell proteins within the NP shell enables precise targeting to...
Published: 5/8/2025
|
Inventor(s): Robert Krencik, Assaf Zinger, Ennio Tasciotti, Caroline Cvetkovic
Keywords(s):
Category(s): Clinical Area > Neurology, Research Area > Neurology and Neurosurgery, Research Area > Nanomedicine, Technology Classifications > Therapeutic > Drug Delivery, Technology Classifications > Therapeutic > Nanovesicles
|